1 min read
Add as a preferred source on Google

Boston Scientific Prices $3 Billion in U.S. Notes and €4.25 Billion in Euro Notes

Boston Scientific priced the U.S. notes across four tranches due from 2029 to 2036. An indirect wholly owned subsidiary priced the euro notes.

Two blank note certificates rest beside coins on a burgundy surface / TokenPost.ai
Two blank note certificates rest beside coins on a burgundy surface / TokenPost.ai

Boston Scientific priced $3 billion in U.S. dollar-denominated senior notes across four tranches, while an indirect wholly owned finance subsidiary priced a separate €4.25 billion euro note offering.

The U.S. notes have maturities ranging from 2029 to 2036. The euro-denominated notes were priced by American Medical Systems Europe B.V., the company's indirect wholly owned finance subsidiary.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…